Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In clinical trials, patients using tirzepatide reported an average weight loss of up to 20% of their body weight over a year
144,145,146,147 Triple agonist Triple agonists go even further
Multi-agonist therapies combining GLP-1 with GIP or glucagon may amplify these benefits by improving fat metabolism and reducing cardiovascular risk even further
Ozempic and other GLP-agonist drugs have changed the weight loss game
Key takeaways About 24% of semaglutide users experience constipation, but it's temporary and mild in 98% of cases
US$ 28.04
US$ 22.46
US$ 22.29
